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Abstract 
 
Background: Ormenis eriolepis Coss (Asteraceae) is an endemic Moroccan subspecies, traditionally named “Hellala” 
or “Fergoga”. It’s usually used for its hypoglycemic effect as well as for the treatment of stomacal pain. As far as we 
know, there is no scientific exploration of anti tumoral activity of Ormenis eriolepis extracts. 
Materials and Methods: In this regard, we performed a screening of organic extracts and fractions in a panel of both 
hematological and solid cancer cell lines, to evaluate the potential in vitro anti tumoral activity and to elucidate the 
respective mechanisms that may be responsible for growth arrest and cell death induction. The plant was extracted 
using organic solvents, and four different extracts were screened on Jurkat, Jeko-1, TK-6, LN229, SW620, U2OS, PC-3 
and NIH3T3 cells. 
Results: Cell viability assays revealed that, the IC50 values were (11,63±5,37µg/ml) for Jurkat, (13,33±1,67µg/ml) for 
Jeko-1, (41,67±1,98µg/ml) for LN229 and (19,31±4,88µg/ml) for PC-3 cells upon treatment with Oe-DF and Oe-HE 
respectively. Both the fraction and extract exhibited no effects on TK6 and NIH3T3. Cytometry analysis accompanied 
by DNA damage signaling protein levels monitoring (p-H2A.X), showed that both the Dichloromethane Fraction and 
Hexanic extract induce DNA double stranded breaks (DSBs) accompanied by cell cycle arrest in G1 (Jurkat, Jeko -1 
and LN22) and G2/M (PC-3) phases which is agreed with the caspase activity observed. Additional experiments with 
selective inhibitors of stress and survival pathways (JNK, MAPK, Rho, p53, and JAK3) indicated that none of these 
pathways was significantly involved in apoptosis induction. The bioactive compound analysis by CG/MS indicated that 
the major compounds in Oe-DF were: Linoleic Acid (15,89%), Podophyllotoxin (17,89%) and Quercetin (22,95%). For 
Oe-HE the major molecules were: Linoleic Acid (9,76%), α-curcumene (7,07%), α-bisabolol (5,49%), Campesterol 
(4,41%), Stigmasterol (14,08%) and β-sitosterol (7,49%). 
Conclusion: Our data suggest that bioactive compounds present in Ormenis eriolepis show significant anti proliferative 
activity inducing cell cycle arrest and cell death operating through apoptosis pathway. 
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Introduction 
 
Plants have been used for medicinal purposes since time immemorial. In recent years, there is strong current 
interest in discovering new edible natural products with medicinal properties. It has been estimated by WHO (World 
Health Organization) (2002) that about 90% of the world’s population from developing countries rely mainly on 
traditional medicines (mostly derived from plants) for their primary health care. In Morocco, the use of traditional 
medicine is widespread practice, the use of plants in the form of infusions or decoctions is a common practice among 
people of rural communities and their use is increasing in urban populations (Gonzalez-Tejero et al., 2008). The 
ethnobotanical and ethnopharmacological surveys conducted in different areas allowed the compilation of an inventory 
of 360 species and more than 500 prescriptions are recorded (Bellakhdar, 1997). 
The genus Ormenis which includes Ormenis eriolepis Coss (Asteraceae) an endemic Moroccan subspecies, 
traditionally named “Hellala” or “Fergoga”. It’s usually used for its hypoglycemic effect as well as for the treatment of 
stomacal pain. Traditionally the inflorescences of this plant are mixed with honey and used for the treatment of the 
cardialgia ulcer and stomacal pain. 
The ability of chemotherapeutic agents to induce apoptosis in tumor cells has become a therapeutic approach which 
may be enhanced by the development of novel approaches during treatment (Gibb et al., 1997). Evidence from various 
studies suggests that metabolites derived from plants may possess pro-apoptotic properties and have great potential for 
possible applications in cancer prevention (Moongkarndi et al., 2004; Kwon et al., 2006; Prasanna et al., 2009; 
Radhika et al., 2010; Choedon et al., 2010).
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Apoptosis  is  characterized  by  particular  morphological changes,  including  plasma  membrane  bleb,  cell 
shrinkage, depolarization of mitochondria, chromatin condensation, DNA fragmentation and cell cycle arrest that can 
be triggered by damage on DNA (Ben-Porath and Weinberg, 2005; Maruyama et al., 2009). 
The p-H2AX has been considered the main signaling protein involved in the response to DNA damage playing an 
important role in DNA repair (Yuan et al., 2010). 
The relationship between apoptosis and cell cycle arrest has been a recent focus. Apoptosis provides a number 
of useful clues when generating effective therapies and many chemotherapeutic agents exert their anticancer effects by 
inducing apoptosis and/or cell cycle arrest in cancer cells (Schuchmann and Galle, 2004). 
As far as we know, there is no scientific exploration of anti tumoral activity of Ormenis eriolepis extracts. In 
this  regard,  the  purpose  of  this  study  was  the  screening  of  organic  extracts  and  fractions  in  a  panel  of  both 
hematological and solid cancer cell lines, to evaluate the potential anti tumoral activity and to elucidate the respective 
mechanisms that may be responsible for growth arrest and cell death induction. Finally, we suggest potential bioactive 
compounds responsible for these effects upon determination of chemical composition of both Oe-DF and Oe-HE by 
GC/MS. 
 
Materials and Methods 
Plant material 
 
The aerial parts of Ormenis eriolepisCoss. (Asteraceae) were collected in 2009 from Ouarzazat (Morocco). 
The plant was identified at the Scientific Institute of Rabat by Prof. M. Fennane, and the specimen was deposited in the 
Scientific Institute herbarium. 
 
Preparation of Extracts 
 
The collected parts were air-dried and mechanically ground to produce a fine powder. 120g of plant powder 
was successively extracted using a Soxhlet apparatus with n-hexane (1.3L) and methanol (1.3L) to obtain hexanic 
extract (Oe-HE 3,91g) and methanolic extract (Oe-ME 10,94g) the resulting extracts were then evaporated by a 
Rotavapor to give dried extracts. The methanol concentrated extract was dissolved in distilled water and was 
successively extracted with dichloromethane (1.3L) and ethyl acetate (1.3L) to obtain dichloromethane fraction (Oe -DF 
3,28g) and ethyl acetate fraction (Oe-AF 3,16g). All extracts were evaporated by a Rotavapor and kept at -20ºC until 
use. 
 
Cell culture 
 
Jurkat, Jeko-1 and TK6 cells were maintained in RPMI-1640 with L-Glutamine and HEPES (Sigma-Aldrich, 
St. Louis, MO). LN229, SW620, U2OS, PC-3 and NIH3T3 cells were maintained in DMEM High Glucose (4.5 g/l) 
with L-glutamine (Invitrogen, Carlsbad, CA). All cells were grown in a humidified incubator at 37ºC with 5% CO2. 
RPMI and DMEM were supplemented with 10% heat inactivated foetal bovine serum and 100 units/ml 
penicillin/streptomycin (Sigma-Aldrich, St. Louis, MO). All cell lines were subconfluently grown and passaged, 
routinely tested for  mycoplasma contamination and  subjected to  frequent morphological tests and  growth curve 
analysis as quality-control assessments. All cell lines were treated at a prophylactic concentration of 5 μg/ml 
Plasmocin™ (InvivoGen, San Diego, CA). 
 
Drugs and inhibitors 
 
SP600125, U0126, H1152, Pifithrin α and JAK3 inhibitor I (Calbiochem, Darmstadt, Germany) were added 
directly to the media at the indicated concentration and cells were harvested or analyzed at the time points indicated in 
the figure legends. 
 
Cell viability assays 
 
The number of viable cells in culture was determined based on quantification of ATP, which signals the 
presence of metabolically-active cells, using the Cell Titer-Glo luminiscent assay kit (Promega, Madison, WI, USA). 
Following the manufacturer’s instructions, the cells were plated in 96-well plates, treated 24 h later with extracts 
dissolved in DMSO for the  indicated times and concentrations, followed by addition of Cell Titer-Glo reagent. 
Luminiscence was detected using a multi-well Synergy Mx scanning spectrophotometer (Biotek, Winooski, VT). 
 
Cell cycle analysis 
 
Cell cycle analysis was performed using propidium iodide staining. Briefly, cells were washed in phosphate- 
buffered saline (PBS) and fixed in 70% ethanol. Fixed cells were then washed twice in PBS and stained in propidium 
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iodide (50 g/ml) in the presence of 50 g/ml RNase A (Sigma-Aldrich, St Louis, MO, USA), then analysed by flow 
cytometry using a FACScan (Coulter Epics XL-MSL; Beckman Coulter, Fullerton, CA, USA) and winMDI software. 
 
Annexin V-FITC/propidium iodide flow cytometric analysis 
 
Analysis of phosphatidylserine externalization in apoptotic cells was determined by an ApoTarget Annexin-V- 
FITC Apoptosis kit (Invitrogen), according to the manufacturer’s instructions. 2 x 105 cells were seeded in 6-well plates 
and treated with 50μg/ml of Mv-DF for 48h. They were then collected and suspended in 100μl of Annexin V-binding 
buffer. 5μL of Annexin-V-FITC and 10μL of propidium iodide were added and incubated 15 min at room temperature 
in the dark. Flow cytometry analysis was carried out using a FACScan (Coulter Epics XL-MSL; Beckman Coulter, 
Fullerton, CA, USA) and winMDI software. 
 
Caspase activity analysis 
 
Enzymatic activity of caspases was determined by measurement of caspases-3 and 7 activity by means of the 
luminometric Caspase-Glo 3/7 assay (Promega) according to the manufacturer’s protocol using a Synergy HT multi- 
detection microplate reader (Bio-Tek, Winooski, VT, USA). 
 
Gel electrophoresis and immunoblotting 
 
Cells were harvested in a buffer containing 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA and 1% 
(v/v) Triton X-100 plus protease and phosphatase inhibitors. Protein content was measured by the Bradford procedure. 
Cell lysates were electrophoresed in SDS-polyacrylamide gels. After electrophoresis, the proteins were transferred to 
Immobilon-P strips (Millipore, Billerica, MA) for 2 h at 60 V. The sheets were pre-incubated in TBS (20 mM Tris-HCl 
pH 7.5, 150 mM NaCl), 0.05% Tween 20 and 5% defatted milk powder for 1 h at room temperature and then incubated 
for 1 h at room temperature in TBS, 0.05% Tween 20, 1% BSA and 0.5% defatted milk powder containing the 
appropriate antibodies: pH2A.X (#9718, 1:1000) and β-tubulin (T0198, Sigma-Aldrich, St. Louis, MO, 1:4000). After 
washing in TBS, 0.05% Tween 20, the sheets were incubated with a peroxidase-coupled secondary antibody (Dako, 
Glostrup, Denmark, 1/2000 dilution,) for 1 h at room temperature. After incubation, the sheets were washed twice in 
TBS, 0.05% Tween 20 and once in TBS. The peroxidase reaction was visualized by the enhanced chemiluminiscence 
detection system (Millipore, Billerica, MA). 
 
Derivatizations for GC/MS analysis 
 
For this purpose, 100µl of the extracts were dried with N2  gas, then 100µl of derivatization agent (N, O-bis 
(trimethylsilyl) trifluoroacetamide with 1% of trimethylchlorosilane) was added, mixed and heated 10 minutes at 60°C. 
 
Gas chromatography/mass spectrometry (GC/MS) analysis 
 
The GC-MS analyses of Ormenis eriolepis Dichloromethane Fraction (Oe-DF) and Hexanic Extract (Oe-HE) 
were carried out at the Instrumental Technical Services of the “Estación Experimental del Zaidín” (CSIC, Granada, 
Spain). Briefly, 1 μl of the derivative solution was injected in a Varian 450GC coupled to 240 Ion Trap Mass 
Spectrometer as detector. The injection conditions were: splitless mode with 1 minute duration pulse, the injector 
temperature was 250°C; the He column flow was 1 ml/minute in a capillary column (Varian Factor Four VF-5 ms 
30mx0.25mmx0.25 μm). For Mass spectrometry conditions, the EI ionization was 70 eV, the transfer line was at 280°C 
and the Trap at 240°C, mass range acquisition was from m/z 50 to m/z 500 and cared in Full Scan mode. Qualitative 
analysis of compounds was based on the comparison of their spectral mass and their relative Retention time with those 
of NIST08 mass spectra database and Kovats RI on the chromatograms recorded in Full Scan or in SIM mode usin g the 
characteristics ions. Quantitative analysis was realized by integration of peaks and calculated as percent of total 
identified area on the TIC chromatograms. 
 
Statistical Analysis 
 
Data are presented as means ± SD of at least three different assays performed in triplicate. IC50 value and the 
statistical significance of differences by Student’s t test were assessed using GraphPad Prism (GraphPad Software Inc. 
La Jolla, CA). Statistically significant differences are indicated by ***P <0.001, **P <0.01 and *P <0.05.
359 
Belayachi et al., Afr J Tradit Complement Altern Med. (2017) 14(2):356-373 
doi:10.21010/ajtcam.v14i2.37 
 
 
Results 
Analysis of the cytotoxic activity of Ormenis eriolepis organic extracts against human cancer cell 
lines. 
 
To investigate the potential effect of Ormenis eriolepis organic extracts against cancer, various hematological 
and solid cancer cell lines of different origin were screened. Non transformed cell lines TK-6 and NIH3T3 were also 
tested as control. Interestingly, both the dichloromethane fraction (Oe-DF) and the hexanic extract (Oe-HE) exhibited 
respectively a dramatic effect against Jurkat and Jeko-1(figure 1A) and LN229 and PC-3 (figure 1B) cells, both 
extracts had no effect against normal cell lines TK-6 and NIH3T3. 
In order to calculate the IC50 , we next performed a dose-response (0-50µg/ml) viability assay using TK-6 as 
control for Jurkat and Jeko-1 and NIH3T3 for LN229 and PC-3 cells. The obtained cell growth curves in Figure 2A and 
2B prove that Oe-DF and Oe-HE exerts a specific dose dependant inhibitory effect on cell proliferation. The IC50 
values were (11,63±5,37µg/ml) for Jurkat and (13,33±1,67µg/ml) for Jeko-1 under Oe-DF treatment and 
(41,67±1,98µg/ml) for LN229, (19,31±4,88µg/ml) for PC-3 cells upon treatment with Oe-HE. Both the fraction and 
extract exhibited no effects on TK6 and NIH3T3 respectively. Doses of 20 μg/ml of Oe-DF and 50 µg/ml of Oe-HE 
were chosen for further mechanistic studies in (Jurkat; jeko-1) and (LN229; PC-3) cells. 
 
 
 
 
 
Figure 1:  Cytotoxic activity of  Ormenis eriolepis organic extracts and fractions in  a  panel of cancer and non- 
transformed cell lines. A. suspension cells panel Jurkat, Jeko-1, and TK-6 and B. adherent cells panel LN229, SW620, 
U2OS, PC-3 and NIH3T3; were incubated for 48 h with 50 µg/ml of each extract and fraction. Results represent the 
mean ±SD of at least 3 independent experiments indicating the percentage of viable cells relative to vehicle-treated 
(control) cells. Statistically significant differences are indicated by ***p < 0.005 compared with untreated. 
 
In order to calculate the IC50 , we next performed a dose-response (0-50µg/ml) viability assay using TK-6 as 
control for Jurkat and Jeko-1 and NIH3T3 for LN229 and PC-3 cells. The obtained cell growth curves in Figure 2A and 
2B prove that Oe-DF and Oe-HE exerts a specific dose dependant inhibitory effect on cell proliferation. The IC50 values 
were (11,63±5,37µg/ml) for Jurkat and (13,33±1,67µg/ml) for Jeko-1 under Oe-DF tratement and (41,67±1,98µg/ml)  
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for LN229, (19,31±4,88µg/ml) for PC-3 cells upon treatement with Oe-HE. Both the fraction and extract exhibited no 
effects on TK6 and NIH3T3 respectively. Doses of 20 μg/ml of Oe-DF and 50 µg/ml of Oe-HE were chosen for further 
mechanistic studies in (Jurkat; jeko-1) and (LN229; PC-3) cells. 
 
 
 
 
Figure 2: (A) Dose-response analysis of Ormenis eriolepis dichloromethane fraction (Oe-DF) and IC50 determination 
on Jurkat and Jeko-1 cells. (B) Dose-response analysis of Ormenis eiriolepis hexanic extract (Oe-HE) and IC50 
determination on LN229 and PC-3 cells. Cells were treated for 48h at different concentrations ranging from 1 to 
50µg/ml; IC50 value (µg/ml) was determined graphically from the viability curves, NIH3T3 and TK6 cells were used as 
control. Data are expressed as means ±SD of triplicate determinations. 
 
Analysis of cell cycle effect of Ormenis eriolepis organic extracts. 
 
In  order  to  investigate  how  cell  cycle  distribution  is  affected,  (jurkat  ;  Jeko-1)  were  treated  with  a 
concentration of 20 µg/ml of Oe-DF and (LN229 ; PC-3 ) with 50µg/ml of Oe-HE for 24 and 48h. As shown in figure 3 
Oe-DF have effectively reduced the proportion of S-phase cells while strongly increased the proportion of Sub G1 cells 
(35,62% for jurkat and 64,75% for jeko-1 at 48h). Whereas Oe-HEin LN229 cells mainly exerts a combination of G1 
arrest and sub- G1 increase at 24h, with this latter population further increasing at 48h up to 42%. In PC-3 cells Oe-HE 
induced a clear G2/M arrest which was already detectable at 24h leading at 48h to a G2/M cell population of 44.11%.
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Figure 3: cell cycle distribution analysis of Jurkat, Jeko-1, LN229 and PC-3 cells treated respectively with Ormenis 
eriolepis Dichloromethane Fraction (Oe-DF) and Hexanic Extract (Oe-HE) by flow cytometry. Jurkat , Jeko-1, LN229 
and PC-3 cells were incubated respectively with 20 µg/ml and 50 µg/ml of Oe-DF and Oe-HE for 24h and 48h. Cells 
were harvested and their DNA content analysed by flow cytometry as described in Materials and Methods. The cell 
cycle distribution is shown for each experimental condition.
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Next, we analyzed the presence of DNA damage by monitoring p-H2A.X levels to investigate the possible 
molecular mechanism of Ormenis eriolepis. As shown in Figure 4, increased levels of p-H2A.X were detected in Oe- 
DF treated cells ( jurkat and jeko-1) as well as in Oe-HE treated cells ( LN229 and PC-3) after 6h to 12h of treatement. 
These results suggest that both the Dichloromethane Fraction and Hexanic extract induce DNA double stranded breaks 
(DSBs) accompanied by cell cycle arrest in G1 (Jurkat, Jeko-1 and LN22) and G2/M (PC-3) phases. 
 
 
 
Figure 4: Effect of Oe-DF and Oe-HE on p-H2AX expression levels in Jurkat, Jeko-1, LN229 and PC-3 cells. Cells (4 
× 10cells /ml) were treated respectively with 20 μg/ml and 50 µg/ml of Oe-DF and Oe-HE for 0, 6 and 12h. p-H2A.X 
levels in cellular extracts were detected by immunoblot with specific antibodies. Tubulin was used as an internal 
control. 
 
 
 
 
 
Effect of Ormenis eriolepis organic extracts on apoptosis induction and caspases activation. 
 
Double Annexin V/Propidium Iodide staining was performed to analyze and quantify cellular death. Upon 
exposure to treatment, an increase in the number of Annexin V positive cells was observed for both Oe-DF and Oe-HE 
as shown in Figure 5. For Jurkat and Jeko-1 cells, a percentage of (11% and 27,9%) was observed at 12h of Oe-DF 
exposure. where LN229 and PC-3 cells have shown an increase of apoptotic cell population of (24% and 20,4%) as well 
after 12h of treatment. 
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Figure 5: Effect of (Oe-DF) in Jurkat and Jeko-1 cell and (Oe-HE) in LN229 and PC-3 on apoptosis induction 
analyzed by flow cytometry. Jurkat , Jeko-1, LN229 and PC-3 cells were incubated respectively with 20 µg/ml and 50 
µg/ml of Oe-DF and Oe-HE for 12h and 24h. The x-axis shows Annexin V-FITC staining and y-axis indicates 
Propidium iodide staining; Lower left (LL) quadrant: viable cells; lower right (LR) quadrant: early apoptotic cells; 
upper left (UL) quadrant: necrotic cells, upper right (UR) quadrant: late apoptotic cells. 
 
Different caspases are activated as a crucial biochemical event during apoptosis. To investigate if Ormenis 
eriolepis induced apoptosis in Jurkat, Jeko-1, LN229 and PC-3 cell lines is caspases dependent, we performed caspase 
3/7 activity assays upon treatment of (Jurkat and Jeko-1) cells with 20µg/ml of Oe-DF and (LN229 and PC-3) cells 
with 50µg/ml of Oe-HE for 48h. Figure 6 prove that both treatments increased caspase activity to 8 and 14 fold up in 
jurkat and jeko-1 cells, while Oe-HE increased similarly the caspase activity to 4 fold up in both LN229 and PC-3 cells 
upon 48h of exposure. Accordingly, this data may suggest that Ormenis eriolepis induced cell death includes caspases 
activation.
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Figure 6: Effect of Ormenis eriolepis Fraction and Extract on caspase activity induction on Jurkat, Jeko-1, LN229 and 
PC-3 cells. (A) Jurkat and Jeko-1 cells were treated with 20 µg/ml of (Oe-DF) for 48h and caspase activity was 
measured (B) LN229 and PC-3 cells were treated with 50 µg/ml of (Oe-HE) for 48h and caspase activity was 
measured. Results indicate the average fold increase ± S.E.M in caspase activity relative to untreated cells from three 
independent determinations performed in duplicate. 
 
Effect of Ormenis eriolepis organic extracts on stress and survival cell pathways. 
 
As a preliminary investigation of the molecular mechanism of  Ormenis eriolepis induced apoptosis, we 
analyzed additional experiments with a panel of selective inhibitors of stress and survival pathways (SP600125, U0126, 
H1152, Pifithrin α and JAK3) performed in (Jurkat and Jeko-1) (figure 7A) and (LN229 and PC-3) (Figure 7B) cells 
upon Oe-DF and Oe-HE treatments at 48h. The results showed that none of these pathways was significantly involved 
in Ormenis eriolepis induced cell death and that neither JNK, ERK1/2, Rho, p53 nor JAK3 pathways seems involved. 
Taken together, this results shows that more molecular investigation is needed to figure out the apoptotic signaling 
regulators responsible of Ormenis eriolepis anti tumoral effect in Jurkat, Jeko-1, LN229 and PC-3 cell lines.
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Figure 7: Effect of Ormenis eriolepis Fraction and Extract on the viability of Jurkat, Jeko-1, LN229 and PC-3 cells in 
presence of a panel of signaling pathways inhibitors. (A) Jurkat and Jeko-1 (B) LN229 and PC-3 cells were untreated or 
treated respectively with 20 and 50 µg/ml of Oe-DF and Oe-HE in the presence or absence of SP600125, U0126; 
H1152, Pifithrin or Jak3 inhibitor (all at 10 µM) for 48h . Inhibitors were pre-incubated for 1 hour before the addition 
of Mv-DF extract. Cell viability is represented as a percentage relative to untreated cells. Data is means ± S.E.M from 
three independent determinations performed in duplicate. 
 
Characterization of chemical compounds in Ormenis eriolepis Dichloromethane Fraction and Hexane Extract. 
 
In order to recognize the bioactive compounds responsible for these effects, Oe-DF and Oe-HE were subjected 
to GC-MS analysis and compounds were identified using mass spectrometry (Figure 8A and 8B).
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Figure 8: (A) Chromatogram of Ormenis eriolepis Dichloromethane Fraction obtained by CG. Compounds were 
identified by computer searches in the reference libraries of NIST and Wiley7, and fragmentation patterns were 
compared with literature Data. Oe-DF constituents are shown in Table 1. (B) Chromatogram of Ormenis eriolepis 
Hexanic Extract obtained by CG. Oe-HE constituents are shown in Table 2. 
 
Retention time, Cas Numbers and % of identified area are summarized in Table 1 and 2. The mass spectra 
compounds  were  matched  with  computer  searches  in  the  references  libraries  of  NIST08  and  Wiley  7,  and 
fragmentation patterns were compared with literature and commercially available products data. The major bioactive 
compounds identified in Oe-DF (Figure 9A) were: Linoleic Acid (15,89%), Podophyllotoxin (17,89%) and Quercetin 
(22,95%). In Oe-HE (Figure 9B) the major molecules were: Linoleic Acid (9,76%), α-curcumene (7,07%), α-bisabolol 
(5,49%), Campesterol (4,41%), Stigmasterol (14,08%) and β-sitosterol (7,49%). 
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Table 1: Compounds present in dichloromethane fraction of Ormenis eiriolepis identified by CG/MS. 
 
RT identified compounds cas numbers % Area 
15,877 Propanoic acid,2-[(trimethylsilyl)oxy]-, trimethylsilyl ester 17596-96-2 0,19604 
16,449 Glycolic acid, TMS 33581-77-0 0,176436 
16,748 2-(Trimethylsiloxy)propenoic acid trimethylsilyl ester 55191-13-4 0,19604 
21,671 Silanol,1,1,1-trimethyl-, 1-benzoate 08/12/2078 0,470496 
22,147 Octanoic acid, trimethylsilyl ester 55494-06-9 0,137228 
23,091 Phenylacetoxytrimethylsilane 2078-18-4 0,352872 
23,531 Butanedioic acid, bis(trimethylsilyl) ester 40309-57-7 0,431288 
23,877 Glyceric acid (3TMS) 38191-87-6 0,09802 
24,787 Nonanoic acid trimethylsilyl ester 82326-11-2 0,176436 
25,247 Benzaldehyde,p-(trimethylsiloxy)- (7CI,8CI) 1012-12-0 0,058812 
27,294 Decanoic acid, trimethylsilyl ester 55494-15-0 0,235248 
27,695 4'-(Trimethylsilyloxy)acetophenone 18803-29-7 0,470496 
27,988 malatate 65143-63-7 0,29406 
29,26 Trimethylsilylvanillin 6689-43-6 0,176436 
29,441 (S)-dihydroactinidiolide 17092-92-1 0,842972 
30,245 α-[(Trimethylsilyl)oxy]benzenepropionic acid trimethylsilyl ester 27750-45-4 0,09802 
31,336 Benzoic acid,4-[(trimethylsilyl)oxy]-, trimethylsilyl ester 2078-13-9 0,646932 
31,889 4-Methoxy-3-(trimethylsiloxy)benzoic acid methyl ester 55590-91-5 0,548912 
33,343 Benzoic acid, 3,4-bis[(trimethylsilyl)oxy]-, methyl ester 27798-58-9 1,137032 
35,023 Nonanedioic acid bis(trimethylsilyl) ester 17906-08-0 2,019212 
35,433 Protocatechuic acid, di-TMS 2347-40-2 0,999804 
35,098 Tetradecanoic acid trimethylsilyl ester 18603-17-3 1,097824 
36,994 3-Methoxy-4-[(trimethylsilyl)oxy]benzenepropionic acid trimethylsilyl 56051-49-1 0,823368 
 ester   
37,06 Benzoic acid,3,5-dimethoxy-4-[(trimethylsilyl)oxy]-, trimethylsilyl 10517-29-0 0,9802 
 ester   
37,919 3-[3-[(Trimethylsilyl)oxy]phenyl]propenoic acid trimethylsilyl ester 32342-01-1 0,999804 
38,883 1,11-Undecanedioic acid, di(trimethylsilyl) ester 106450-25-3 0,842972 
39,199 3-[3,4-Bis(trimethylsilyloxy)phenyl]propenoic acid methyl ester 22020-29-7 2,372084 
41,57 2-Propenoic acid, 3-[3,4-bis[(trimethylsilyl)oxy]phenyl]-, trimethylsilyl 
ester 
10586-03-5 1,86238 
42,53 ALMITIC ACID N-BUTYL ESTER 111-06-8 1,431092 
42,91 Linoleic acid trimethylsilyl 56259-07-5 15,89884 
43,458 Octadecanoic acid, trimethylsilyl ester 18748-91-9 4,901 
46,698 Eicosanoic acid, trimethylsilyl ester 55530-70-6 2,078024 
48,896 Hexadecanoic acid 2,3-bis[(trimethylsilyl)oxy]propyl ester 1188-74-5 8,586552 
49,699 Docosanoic acid trimethylsilyl ester 74367-36-5 2,920996 
51,665 Stearic acid 2,3-bis(trimethylsilyloxy)propyl ester 1188-75-6 4,587336 
55,302 Podophyllotoxin 518-28-5 17,89845 
56,24 Quercetin, penta-TMS 4067-66-7 22,95824 
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Table 2: Compounds present in the hexanic extarct of Ormenis eiriolepis identified by 
CG/MS 
 
RT identified compounds cas numbers % Area 
15,879 2-(Trimethylsiloxy)propanoic acid trimethylsilyl ester 17596-96-2 0,14554795 
16,377 Hexanoic acid, trimethylsilyl ester 14246-15-2 0,06849315 
16,453 Glycolic acid, bis-TMS 33581-77-0 0,08561644 
22,162 Octanoic acid, trimethylsilyl ester 55494-06-9 0,08561644 
24,802 Nonanoic acid trimethylsilyl ester 82326-11-2 0,11986301 
27,301 Decanoic acid, trimethylsilyl ester 55494-15-0 0,65924658 
28,018 alpha-curcumene 644-30-4 7,07191781 
28,697 (+)-aromadendrene 489-39-4 0,72773973 
29,368 (S)-dihydroactinidiolide 17092-92-1 0,10273973 
32,891 alpha-Bisabolol 515-69-5 5,49657534 
35,032 Nonanedioic acid bis(trimethylsilyl) ester 17906-08-0 0,39383562 
36,112 Tetradecanoic acid trimethylsilyl ester 18603-17-3 0,65924658 
39,968 Hexadecanoic acid, trimethylsilyl ester 55520-89-3 4,29794521 
41,732 Heptadecanoic acid, trimethylsilyl ester 55517-58-3 0,64212329 
42,728 1,2-Hexadecanediol 6920-24-7 0,59075342 
42,949 Linoleic acid trimethylsilyl 56259-07-5 9,76883562 
43,096 alpha-Linolenic acid, trimethylsilyl ester 97844-13-8 15,3424658 
43,467 Octadecanoic acid, trimethylsilyl ester 18748-91-9 2,43150685 
46,707 Eicosanoic acid, trimethylsilyl ester 55530-70-6 1,27568493 
48,372 1-Docosanol 661-19-8 6,59246575 
48,897 Hexadecanoic acid 2,3-bis[(trimethylsilyl)oxy]propyl ester 1188-74-5 3,3989726 
49,711 Docosanoic acid trimethylsilyl ester 74367-36-5 2,40582192 
51,26 1-TETRACOSANOL 506-51-4 7,32020548 
54,002 Icosanoic acid 2,3-bis(trimethylsilyloxy)propyl ester 55517-94-7 1,54109589 
54,638 Hexacosanoic Acid 506-46-7 2,66267123 
57,21 CAMPESTEROL 474-62-4 4,41780822 
57,567 Stigmasterol trimethylsilyl ether 14030-29-6 14,0839041 
58,444 β-Sitosteryl trimethylsilyl ether 2625-46-9 7,49143836 
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Figure 9: (A) Chemical structures of the major bioactive compounds of Ormenis eriolepis Dichloromethane Fraction. 
(B) Chemical structures of the major bioactive compounds of Ormenis eriolepis Hexanic Extract. 
 
 
 
Discussion 
 
After the rapid expansion of the use of monoclonal antibodies and various synthetic inhibitors directed against 
matrix metalloproteases or protein kinases, natural products are regaining attention in the oncology field. Due to their 
wide range of biological activities and low toxicity in animal models, natural products have been used as alternative 
treatments for cancers (Newman and Cragg 2012). Several drugs currently used in chemotherapy were isolated from 
plant species. The best known are the Vinca alkaloids, vinblastine and vincristine, isolated from Catharanthus roseus, 
etoposide and teniposide, which are semi-synthetic derivatives of the natural product epipodophyllotoxin, Paclitaxel 
isolated from the barkof Taxus brevifolia, the semi-synthetic derivatives of camptothecin, irinotecan and topotecan, 
isolated from Camptotheca acuminata, among several others (Cragg et al., 1993) 
All Cancer cells are characterized by unregulated growth, as well as insufficient and inappropriate vascular supply 
(Tomida and Tsuruo, 1999). 
T-cell lymphoblastic leukemia (Jurkat), Mantle cell lymphoma (Jeko-1), Glioblastoma multiforme (LN229) 
and Prostate Cancer (PC-3) are cell lines models for aggressive neoplastic disorders; they are known to have alteration 
in multiple cellular pathways including apoptosis. Deficiencies in this last, contribute to carcinogenesis by creating a 
permissive environment for genetic instability and accumulation of gene mutations conferring resistance to cytotoxic 
anticancer drugs and radiation (Irwin et al.;2013). 
Ormenis eriolepis Coss (Asteraceae) an endemic Moroccan subspecies, traditionally named “Hellala” or 
“Fergoga” used for its hypoglycemic effect as well as for the treatment of stomacal pain. As far as we know, there is no 
scientific exploration of the anti-tumor capacity of Ormenis eriolepis extracts. In this study, we present the first 
evidence of tumor cell growth inhibitory activity of Oe-DF and Oe-HE by using in vitro experimental models. We 
show that both organic extract decreased specifically the viability of Jurkat, Jeko-1, LN229 and PC-3 cell lines in a 
dose specific manner, while it did not affect non-transformed human lymphocyte and mice fibroblasts TK-6 and 
NIH3T3. 
Disturbance of the cancer cell cycle is one of the therapeutic targets for development of new anticancer drugs 
(Carnero; 2002). Analytical results indicate that Oe-DF have effectively reduced the proportion of S-phase cells while 
strongly increased the proportion of Sub G1 cells. Whereas Oe-HE in LN229 cells mainly exerts a combination of G1 
arrest and sub- G1 increase at 24h, with this latter population further increasing at 48h up. In PC-3 cells Oe-HE induced
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a clear G2/M arrest which was already detectable at 24h. Therefore, a mechanism inducing cell cycle arrest and 
senescence can be triggered by damage on DNA (Ben-Porath and Weinberg, 2005; Maruyama et al., 2009). The 
occurrence of phosphorylation on histone H2AX, namely γ-H2AX, has been widely used as a sensitive marker of DNA 
damage. Both Oe-DF and Oe-HE increased γ-H2AX levels after 6h to 12h of treatment. Clearly, more specific studies 
are needed to investigate how Oe-DF and Oe-HE affect key proteins involved in cell cycle control in the four sensitive 
cell lines, namely P53, P16, P21, Cyclin dependant kinase and cyclins. Therefore, these findings point to the cycle 
arrest is being caused by a sophisticated mechanism in which the actions are initiated by DNA double stranded breaks. 
The process of programmed cell death, or apoptosis is an important homeostatic mechanism that balances cell 
division and cell death to maintain appropriate cell number in tissues (Elmore ; 2007). Flow cytometry analysis upon 
Annexin-V/propidium iodide staining detects and quantifies the amount of cells undergoing apoptosis. Up on exposure 
to treatment, an increase in the number of Annexin V positive cells was observed for both Oe-DF and Oe-HE in Jurkat 
and Jeko-1 cells, LN229 and PC-3 cells respectively in a time-dependent manner, demonstrating that Ormenis eriolepis 
induces cell death through the promotion of apoptosis. 
Apoptosis signal transduction and execution require the coordinated action of the cascade of 
caspases (asparate-specific cysteine proteases). Caspases are expressed as inactive proenzymes and become activated 
by proteolytic processing at internal aspartate residues when cells receive an apoptosis-inducing signal. At present 14 
mammalian caspase family members have been described. Some, including caspases-2, -8, -9 and -10 are initiators of 
cell death (contain large prodomains). Once activated, these initiator caspases in turn activate the executioner caspases 
such as caspases-3, -6 and -7 (carry small prodomains). Thus, caspases can activate each other (Takahashi, 1998). For 
this purpose, we determined if the enzymatic activity of caspase 3 and 7 was increased in Jurkat and Jeko-1 under Oe- 
DF treatment, as well as LN229 and PC-3 under Oe-HE. Data shows, that both treatments increased caspase activity 
upon 48h of exposure. Which may suggest that Ormenis eriolepis induced cell death may include caspases activation. 
Apoptosis can  be  mediated  by  several  pathways  that  may  involve  complex  molecular  interactions and 
biochemical regulators. As a very preliminary investigation, we analyzed the effect of a panel of stress and survival 
pathways inhibitors in Jurkat, Jeko-1, LN229 and PC-3 cell lines under their respective Ormenis eriolepis treatment. 
For this regard, JNK inhibitor SP600125, the MEK inhibitor U0126, the Rho inhibitor H1152, the p53 inhibitor 
pifithrin α and the JAK3 inhibitor were used. As shown, none of these inhibitors protected the studied cell lines from 
Ormenis eriolepis induced cell death. However, further detailed investigations are needed to elucidate the mechanism 
of action in Jurkat, Jeko-1, LN229 and PC-3 cells in order to obtain definite conclusions. 
In this study, GC-MS analysis was conducted on both Oe-DF and Oe-HE in order to recognize the bioactive 
compounds responsible for these effects. The major bioactive compounds identified in Oe-DF were: Linoleic Acid 
(15,89%), Podophyllotoxin (17,89%) and Quercetin (22,95%). In Oe-HE the major molecules were: Linoleic Acid 
(9,76%), α-curcumene (7,07%), α-bisabolol (5,49%), Campesterol (4,41%), Stigmasterol (14,08%) and β-sitosterol 
(7,49%). 
Remarkably, all  these identified compounds are  known for  their  cytotoxic activity against cancer cells. 
Podophyllotoxin, it is effective in the treatment of Wilms tumours, different types of genital tumors (carcinoma 
verrucosus, for example) and in non-Hodgkin and other lymphomas (Ayres and Loike, 1990) and lung cancer (Utsugi 
et al., 1996; Subrahmanyam et al., 1998). Three semisynthetic derivatives of podophyllotoxin, etoposide, teniposide 
and etopophos, were widely used as anticancer drugs and show good clinical effects against several types of neoplasms 
including testicular and small-cell lung cancers, lymphoma, leukaemia, Kaposi’s sarcoma, etc (Ayres and Loike, 1990). 
Numerous studies have described the cancer preventive effects and molecular mechanisms of quercetin, which 
has been shown to one of the major flavonoids with antiproliferative efficacy on a wide range of cancer cells (Boyer et 
al., 2004; Kang and Liang, 1997; Suh et al., 2010). For example, quercetin was shown to inhibit the growth of acute 
lymphoid and myeloid leukemia cells (Kang and Liang, 1997). It was also reported to have growth-inhibitory effects on 
human gastric and colon cancer cells by inhibiting cell cycle progression at the G1-S boundary (Suh et al., 2010). These 
diverse antitumor activities of quercetin make it a lead compound for the development of new effective cancer 
preventive or therapeutic agents. α-bisabolol is a small oily sesquiterpene alcohol that has been demonstrated to have 
activity against some malignant adherent human and rat cell lines and against spontaneous mammary tumors in HER-2 
transgenic mice as well as in HepG2 and Glioma cells (Costarelli et al. 2010;. Darra et al.; 2008; Chen et al.; 2010). 
Campesterol, β-sitosterol and stigmasterol displayed remarkable cytotoxic activity against A549 cells. These 
in vitro data support findings that a mixture consisting of these three sterols exerted cytotoxic activity against cancer 
cells  (Lai  et  al.,  2010).  Notably,  β-sitosterol  induced  G2/M  arrest,  endoreduplication,  and  apoptosis  on  U937 
lymphoma cells and HL60 promyelocytic leukemic cells through the Bcl-2 and PI3K/Akt signaling pathways (Moon et 
al., 2008). Stigmasterol maintained a non-dose-responsive inhibition of growth (around 40–50% inhibition between 1.6 
and 50 µg/ml) of HS578T breast cancer cells (Lai et al., 2010). 
 
Conclusions 
 
Our  study  findings  support  the  notion  that  Ormenis  eriolepis  have  a  combination of  several  bioactive 
compounds that  can  be  responsible either  alone  or  together  for  its  outstanding antitumor  activity and  also  the 
chemoprevention proprieties that can have the plant decoction if used regularly in healthy diet, brings a clear scientific 
support to the use of Moroccan medicinal plants by traditional healers for the treatment of cancer patients. Fi nally and
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as preliminary information, it opens the way for further investigations to elucidate the possible molecular mechanisms 
involved in cancer cell death and cell cycle arrest. 
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